Margaret Dalesandro - Sep 1, 2021 Form 4 Insider Report for SEELOS THERAPEUTICS, INC. (SEEL)

Role
Director
Signature
/s/ Margaret Dalesandro, Ph.D.
Stock symbol
SEEL
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/2/2021, 04:08 PM
Previous filing
Aug 25, 2021
Next filing
Sep 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SEEL Stock Option (right to buy) Award $0 +42K $0.00 $42K Sep 1, 2021 Common Stock 42K $2.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares subject to the option shall vest on September 1, 2022, and 1/36th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date.